---
figid: PMC8834883__fphar-12-813703-g004
figtitle: 'Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment
  Strategies and Pharmacological Interventions'
organisms:
- Saccharomyces cerevisiae
- Angelica sinensis
- Morus alba
- Perilla frutescens
- Gardenia jasminoides
- Lentinula edodes
- Cladophora subtilissima
- Saussurea costus
- Dioscorea nipponica
- Amorphophallus konjac
- Mallotus philippensis
- Adenophora triphylla
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Helicobacter pylori
- Periplaneta americana
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
- Caenorhabditis elegans
pmcid: PMC8834883
filename: fphar-12-813703-g004.jpg
figlink: /pmc/articles/PMC8834883/figure/F4/
number: F4
caption: Several signaling pathways modulating autophagy in gastric cancer treatment.
  AMPK/ULK1 inhibits mTOR pathway, which positively activates autophagy induction.
  Neurotransmitter and miRNA regulate autophagy induction. However, autophagy-related
  gene (ATG), 3-metheylalanine (3-MA), chloroquine (CQ), bafilomycin A1 (BAF-1), and
  nonsteroidal anti-inflammatory drugs (NSAIDs) inhibited and modulated entire autophagy
  process. β2-Adrenergic receptor activates beclin-1 and inhibits autophagy.
papertitle: 'Potential Therapeutic Action of Autophagy in Gastric Cancer Managements:
  Novel Treatment Strategies and Pharmacological Interventions.'
reftext: Md. Ataur Rahman, et al. Front Pharmacol. 2021;12:813703.
year: '2021'
doi: 10.3389/fphar.2021.813703
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: gastric cancer | autophagy | phytochemical | tumorigenesis | autophagy-related
  genes | autophagy modulator
automl_pathway: 0.9588159
figid_alias: PMC8834883__F4
figtype: Figure
redirect_from: /figures/PMC8834883__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8834883__fphar-12-813703-g004.html
  '@type': Dataset
  description: Several signaling pathways modulating autophagy in gastric cancer treatment.
    AMPK/ULK1 inhibits mTOR pathway, which positively activates autophagy induction.
    Neurotransmitter and miRNA regulate autophagy induction. However, autophagy-related
    gene (ATG), 3-metheylalanine (3-MA), chloroquine (CQ), bafilomycin A1 (BAF-1),
    and nonsteroidal anti-inflammatory drugs (NSAIDs) inhibited and modulated entire
    autophagy process. β2-Adrenergic receptor activates beclin-1 and inhibits autophagy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Prom1
  - Ulk1
  - Mtor
  - Rab7
  - PROM1
  - ULK1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - BECN1
  - RAB5A
  - RAB7A
  - RAB7B
  - Atg1
  - SNF4Agamma
  - AMPKalpha
  - Tor
  - Atg6
  - Rab5
  - baf-1
  - rab-5
  - rab-7
---
